Javascript must be enabled to continue!
Fatty liver formation in fulminant type 1 diabetes
View through CrossRef
SummaryA 32-year-old woman presented with 3days of epigastric pain and was admitted to our hospital (day 3 of disease). We diagnosed acute pancreatitis based on epigastric abdominal pain, hyperamylasemia, and an inflammatory reaction of withdrawn blood, pancreatic enlargement, and so on. Her condition improved with treatment; however, on day 8, she had decreased level of consciousness. Laboratory results led to a diagnosis of fulminant type 1 diabetes mellitus (FT1DM) with concomitant diabetic ketoacidosis. Insulin therapy improved her blood glucose levels as well as her symptoms. Fatty liver with liver dysfunction was observed on day 14, which improved by day 24. Blood levels of free fatty acids (FFAs) increased rapidly from 440μEq/L (normal range: 140–850μEq/L) on day 4 to 2097μEq/L on days 7–8 (onset of FT1DM) and subsequently decreased to 246μEq/L at the onset of fatty liver. The rapid decrease in insulin at the onset of FT1DM likely freed fatty acids derived from triglycerides in peripheral adipocytes into the bloodstream. Insulin therapy rapidly transferred FFAs from the periphery to the liver. In addition, insulin promotes thede novosynthesis of triglycerides in the liver, using newly acquired FFAs as substrates. At the same time, inhibitory effects of insulin on VLDL secretion outside of the liver promote the accumulation of triglycerides in the liver, leading to fatty liver. We describe the process by which liver dysfunction and severe fatty liver occurs after the onset of FT1DM, from the perspective of disturbed fatty acid metabolism.Learning pointsFT1DM is rare but should be considered in patients with pancreatitis and a decreased level of consciousness.Fatty liver should be considered in patients with FT1DM when liver dysfunction is observed.Insulin is involved in mechanisms that promote fatty liver formation.Pathophysiological changes in fatty acid metabolism may provide clues on lipid metabolism in the early phases of FT1DM.
Title: Fatty liver formation in fulminant type 1 diabetes
Description:
SummaryA 32-year-old woman presented with 3days of epigastric pain and was admitted to our hospital (day 3 of disease).
We diagnosed acute pancreatitis based on epigastric abdominal pain, hyperamylasemia, and an inflammatory reaction of withdrawn blood, pancreatic enlargement, and so on.
Her condition improved with treatment; however, on day 8, she had decreased level of consciousness.
Laboratory results led to a diagnosis of fulminant type 1 diabetes mellitus (FT1DM) with concomitant diabetic ketoacidosis.
Insulin therapy improved her blood glucose levels as well as her symptoms.
Fatty liver with liver dysfunction was observed on day 14, which improved by day 24.
Blood levels of free fatty acids (FFAs) increased rapidly from 440μEq/L (normal range: 140–850μEq/L) on day 4 to 2097μEq/L on days 7–8 (onset of FT1DM) and subsequently decreased to 246μEq/L at the onset of fatty liver.
The rapid decrease in insulin at the onset of FT1DM likely freed fatty acids derived from triglycerides in peripheral adipocytes into the bloodstream.
Insulin therapy rapidly transferred FFAs from the periphery to the liver.
In addition, insulin promotes thede novosynthesis of triglycerides in the liver, using newly acquired FFAs as substrates.
At the same time, inhibitory effects of insulin on VLDL secretion outside of the liver promote the accumulation of triglycerides in the liver, leading to fatty liver.
We describe the process by which liver dysfunction and severe fatty liver occurs after the onset of FT1DM, from the perspective of disturbed fatty acid metabolism.
Learning pointsFT1DM is rare but should be considered in patients with pancreatitis and a decreased level of consciousness.
Fatty liver should be considered in patients with FT1DM when liver dysfunction is observed.
Insulin is involved in mechanisms that promote fatty liver formation.
Pathophysiological changes in fatty acid metabolism may provide clues on lipid metabolism in the early phases of FT1DM.
Related Results
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Background and Introduction: Non-alcoholic fatty liver disease (NAFLD) has been demonstrated that insulin resistance and metabolic syndrome are associated with non-alcoholic fatty ...
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
Objective:
This preliminary investigation aimed to assess the value of two elastography techniques, sound touch elastography (STE) and sound touch
quantification (STQ), in measurin...
Correlation between Ultrasound Grading of Diffuse Fatty Liver Changes with Density of Liver Measured by Computed Tomography Scan
Correlation between Ultrasound Grading of Diffuse Fatty Liver Changes with Density of Liver Measured by Computed Tomography Scan
Ultrasound is a good imaging modality for diagnosing and grading fatty liver disease. It is an effective method for quantifying fatty liver alterations since it can be used to esti...
Diabetes Mellitus: Life Style, Obesity and Insulin Resistance
Diabetes Mellitus: Life Style, Obesity and Insulin Resistance
In millennia, 40 million people were died with non-communicable diseases and diabetes is one of them. In diabetes, insulin secretions are not produced properly or resist to body an...
Undiagnosed Diabetes in Acute Coronary Syndrome: A Silent Threat in Pakistan
Undiagnosed Diabetes in Acute Coronary Syndrome: A Silent Threat in Pakistan
Diabetes mellitus (DM) has emerged as one of the most pressing public health challenges globally, and Pakistan stands among the countries most severely affected. With rising urbani...
A Multi-Polygenic Risk Score Approach Incorporating Physical Activity Genotypes for Predicting Type 2 Diabetes and Associated Comorbidities: A FinnGen Study
A Multi-Polygenic Risk Score Approach Incorporating Physical Activity Genotypes for Predicting Type 2 Diabetes and Associated Comorbidities: A FinnGen Study
ABSTRACT
Aims/hypothesis
Genetic prediction of type 2 diabetes risk has proven difficult using current methods. Recent studies ...

